Search Results - Yu. V. Gagarina

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Cost-effectiveness of using sodium-glucose cotransporter type 2 inhibitors as a part of therapy for cardiovascular death prevention and achieving the Reduction of Cardiovascular Mortality indicator of the Healthcare Development state program in patients with chronic kidney disease and resistant hypertension

    Cost-effectiveness of using sodium-glucose cotransporter type 2 inhibitors as a part of therapy for cardiovascular death prevention and achieving the Reduction of Cardiovascular Mo... by M. V. Zhuravleva, Yu. V. Gagarina, T. V. Marin

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings

    Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings by M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Cost-effectiveness of dapagliflozin as part of various treatment regimens for prevention of cardiovascular death and achieving the target indicator "Reduction of cardiovascular mortality" of the State Program "HealthCare Development" in patients with heart failure with reduced ejection fraction

    Cost-effectiveness of dapagliflozin as part of various treatment regimens for prevention of cardiovascular death and achieving the target indicator "Reduction of cardiovascular mor... by M. V. Zhuravleva, S. V. Nedogoda, Yu. V. Gagarina, T. V. Marin

    Published 2024-08-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy

    Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy by M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure

    Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "H... by M. V. Zhuravleva, S. N. Tereshchenko, F. N. Paleev, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure

    Effect of dapagliflozin therapy on achieving cardiovascular mortality target indicators in patients with heart failure by M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Villevalde, T. V. Marin, Yu. V. Gagarina

    Published 2022-01-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Effect of dapagliflozin in patients with heart failure on reducing cardiovascular mortality in federal project on the prevention of cardiovascular diseases

    Effect of dapagliflozin in patients with heart failure on reducing cardiovascular mortality in federal project on the prevention of cardiovascular diseases by M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Villevalde, T. V. Marin, Yu. V. Gagarina

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Effect of ticagrelor in patients with acute coronary syndrome on the achievement of the targets of federal project on the prevention of cardiovascular diseases: 3-year perspective estimates

    Effect of ticagrelor in patients with acute coronary syndrome on the achievement of the targets of federal project on the prevention of cardiovascular diseases: 3-year perspective... by M. V. Zhuravleva, F. N. Paleev, S. K. Zyryanov, A. N. Yakovlev, T. V. Marin, Yu. V. Gagarina

    Published 2020-12-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025

    Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target... by M. V. Zhuravleva, S. K. Zyryanov, F. N. Paleev, A. N. Yakovlev, Yu. V. Gagarina, T. V. Marin

    Published 2024-02-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Evaluation of the effect of the use of the drug ticagrelor in patients with acute coronary syndrome on achieving the target indicator “reduction of mortality from diseases of the circulatory system” in 2022-2024

    Evaluation of the effect of the use of the drug ticagrelor in patients with acute coronary syndrome on achieving the target indicator “reduction of mortality from diseases of the c... by M. V. Zhuravleva, S. K. Zyryanov, F. N. Paleev, A. N. Yakovlev, T. V. Marin, Yu. V. Gagarina

    Published 2022-01-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction

    Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health... by M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Nedogoda, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: